Chemotherapy-induced amenorrhea: A prospective study of brain activation changes and neurocognitive correlates

Brain Imaging and Behavior

Volumn 7, Issue 4, 2013, Pages 491-500

  Conroy, Susan K ^a,b   McDonald, Brenna C ^a,b,c   Ahles, Tim A ^c,d   West, John D ^a   Saykin, Andrew J ^a,b,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Amenorrhea; Breast cancer; Chemotherapy; Functional MRI

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ESTRADIOL; TAMOXIFEN; TRASTUZUMAB;

ADULT; AMENORRHEA; ARTICLE; BRAIN; BRAIN FUNCTION; BREAST CANCER; CANCER CHEMOTHERAPY; CHEMOTHERAPY INDUCED AMENORRHEA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; INFORMATION PROCESSING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE SCANNER; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RESPONSE TIME; TASK PERFORMANCE; WORKING MEMORY;

ADULT; AGED; AMENORRHEA; ANTINEOPLASTIC AGENTS; BRAIN; BREAST NEOPLASMS; COGNITION DISORDERS; FEMALE; HUMANS; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84901339611     PISSN: 19317557     EISSN: 19317565     Source Type: Journal    
DOI: 10.1007/s11682-013-9240-5     Document Type: Article

References (56)

1. Ahles, T. A., & Saykin, A. J. (2007). Candidate mechanisms for chemotherapy-induced cognitive changes. Nature Reviews Cancer, 7(3), 192-201.
2. Ahles, T. A., Saykin, A. J., McDonald, B. C., Furstenberg, C. T., Cole, B., Hanscom, B. S., Mulrooney, T. J., Schwartz, G., & Kaufman, P. A. (2008). Cognitive function in breast cancer patients prior to adjuvant treatment. Breast Cancer Research and Treatment, 110, 143-152.
3. Ahles, T. A., Saykin, A. J., McDonald, B. C., Li, Y., Furstenberg, C. T., Hanscom, B. S., Mulrooney, T. J., Schwartz, G. N., & Kaufman, P. A. (2010). Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. Journal of Clinical Oncology, 28(29), 4434-4440.
4. Barona, A., Reynolds, C. R., & Chastain, R. (1984). A demographically based index of pre-morbid intelligence for theWAIS-R. Journal of Consulting and Clinical Psychology, 52(5), 885-887.
5. Berman, K. F., Schmidt, P. J., Rubinow, D. R., Danaceau, M. A., Van Horn, J. D., Esposito, G., Ostrem, J. L., & Weinberger, D. R. (1997). Modulation of cognition-specific cortical activity by gonadal steroids: a positron-emission tomography study in women. Proceedings of the National Academy of Sciences of the United States of America, 94(16), 8836-8841.
6. Brett, M., Anton, J.-L., Valabregue, R., Poline, J.-B. (2002). Region of interest analysis using an SPM toolbox: presented at the 8th International Conference on Functional Mapping of the Human Brain, June 2-6, 2002, Sendai, Japan. NeuroImage, 16(2).
7. Brinton, R. D. (2009). Estrogen-induced plasticity from cells to circuits: predictions for cognitive function. Trends in Pharmacological Sciences, 30(4), 212-222.
8. Brown, F. C., Roth, R. M., Saykin, A. J., & Beverly-Gibson, G. (2007). A new measure of visual location learning and memory: development and psychometric properties for the Brown Location Test (BLT). Clinical Neuropsychology, 21(5), 811-825.
9. Cimprich, B., Reuter-Lorenz, P., Nelson, J., Clark, P. M., Therrien, B., Normolle, D., Berman, M. G., Hayes, D. F., Noll, D. C., Peltier, S., & Welsh, R. C. (2010). Prechemotherapy alterations in brain function in women with breast cancer. Journal of Clinical and Experimental Neuropsychology, 32(3), 324-331.
10. Clement, F., & Belleville, S. (2010). Compensation and disease severity on the memory-related activations in mild cognitive impairment. Biological Psychiatry, 68(10), 894-902.
11. Craft, S., Newcomer, J., Kanne, S., Dagogo-Jack, S., Cryer, P., Sheline, Y., Luby, J., Dagogo-Jack, A., & Alderson, A. (1996). Memory improvement following induced hyperinsulinemia in Alzheimer's disease. Neurobiology of Aging, 17(1), 123-130.
12. Craig, M. C., Fletcher, P. C., Daly, E. M., Rymer, J., Cutter, W. J., Brammer, M., Giampietro, V., Wickham, H., Maki, P. M., & Murphy, D. G. (2007). Gonadotropin hormone releasing hormone agonists alter prefrontal function during verbal encoding in young women. Psychoneuroendocrinology, 32(8-10), 1116-1127.
13. Craig, M. C., Fletcher, P. C., Daly, E.M., Picchioni, M.M., Brammer, M., Giampietro, V., Rymer, J., McGuire, P. K., Maki, P. M., & Murphy, D. G. (2008a). A study of visuospatial working memory pre-and post-Gonadotropin Hormone Releasing Hormone agonists (GnRHa) in young women. Hormones and Behavior, 54(1), 47-59.
14. Craig, M. C., Fletcher, P. C., Daly, E. M., Rymer, J., Brammer, M., Giampietro, V., Maki, P. M., Murphy, D. G., Craig, M. C., Fletcher, P. C., Daly, E. M., Rymer, J., Brammer, M., Giampietro, V., Maki, P. M., & Murphy, D. G. M. (2008b). Reversibility of the effects of acute ovarian hormone suppression on verbal memory and prefrontal function in pre-menopausal women. Psychoneuroendocrinology, 33(10), 1426-1431.
15. de Ruiter, M. B., Reneman, L., Boogerd, W., Veltman, D. J., van Dam, F. S., Nederveen, A. J., Boven, E., & Schagen, S. B. (2011). Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Human Brain Mapping, 32(8), 1206-1219.
16. Delis, D. C., Kramer, J. H., Kaplan, E., & Ober, B. A. (1987). The California verbal learning test. San Antonio: Psychological Corporation.
17. Delis, D. C., Kramer, J. H., Kaplan, E., & Ober, B. A. (2000). Californial verbal learning test, 2nd ed. adult version manual. San Antonio: The Psychological Corporation.
18. Delis, D. C., Kaplan, E., & Kramer, J. H. (2001). The Delis-Kaplan executive function system. San Antonio: The Psychological Corporation.
19. Doncarlos, L. L., Azcoitia, I., & Garcia-Segura, L. M. (2009). Neuroprotective actions of selective estrogen receptor modulators. Psychoneuroendocrinology, 34(Suppl 1), S113-S122.
20. Fischer, J. S., Jak, A. J., Kniker, J. E., Rudick, R. A. (2001). Administration and scoring manual for the Multiple Sclerosis Functional Composite Measure (MSFC). National Multiple Sclerosis Society.
21. Fox, M. D., Snyder, A. Z., Vincent, J. L., Corbetta, M., Van Essen, D. C., & Raichle, M. E. (2005). The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proceedings of the National Academy of Sciences of the United States of America, 102(27), 9673-9678.
22. Ganz, P. A., Land, S. R., Geyer, C. E., Cecchini, R. S., Costantino, J. P., Pajon, E. R., Fehrenbacher, L., Atkins, J. N., Polikoff, J. A., Vogel, V. G., Erban, J. K., Livingston, R. B., Perez, E. A., Mamounas, E. P., Wolmark, N., & Swain, S. M. (2011). Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial. Journal of Clinical Oncology, 29(9), 1110-1116.
23. Henderson, V. W., & Brinton, R. D. (2010). Menopause and mitochondria: windows into estrogen effects on Alzheimer's disease risk and therapy. Progress in Brain Research, 182, 77-96.
24. Henderson, V. W., & Sherwin, B. B. (2007). Surgical versus natural menopause: cognitive issues. Menopause, 14(3 Pt 2), 572-579.
25. Hermelink, K., Untch, M., Lux, M. P., Kreienberg, R., Beck, T., Bauerfeind, I., & Munzel, K. (2007). Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Cancer, 109(9), 1905-1913.
26. Hermelink, K., Henschel, V., Untch, M., Bauerfeind, I., Lux, M. P., Munzel, K., Hermelink, K., Henschel, V., Untch, M., Bauerfeind, I., Lux, M. P., & Munzel, K. (2008). Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study. Cancer, 113(9), 2431-2439.
27. Jansen, C. E., Miaskowski, C., Dodd, M., Dowling, G., Kramer, J., Jansen, C. E., Miaskowski, C., Dodd, M., Dowling, G., & Kramer, J. (2005). A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer, 104(10), 2222-2233.
28. Jenkins, V., Shilling, V., Deutsch, G., Bloomfield, D., Morris, R., Allan, S., Bishop, H., Hodson, N., Mitra, S., Sadler, G., Shah, E., Stein, R., Whitehead, S., & Winstanley, J. (2006). A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. British Journal of Cancer, 94(6), 828-834.
29. Jim, H. S. L., Phillips, K. M., Chait, S., Faul, L. A., Popa, M. A., Lee, Y.-H., Hussin, M. G., Jacobsen, P. B., & Small, B. J. (2012). Metaanalysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. Journal of Clinical Oncology, 30(29), 3578-3587.
30. Kesler, S. R., Kent, J. S., & O'Hara, R. (2011). Prefrontal cortex and executive function impairments in primary breast cancer. Archives of Neurology, 68(11), 1447-1453.
31. Lafayette Instrument. (1989). Grooved pegboard: Instruction/owner's manual. Lafayette: Lafayette Instrument.
32. McDonald, B. C., Conroy, S. K., Ahles, T. A., West, J. D., & Saykin, A. J. (2010). Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study. Breast Cancer Research and Treatment, 123(3), 819-828.
33. McDonald, B. C., Conroy, S. K., Ahles, T. A., West, J. D., Saykin, A. J. (2012). Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional MRI study. Journal of Clincal Oncology, 30(20), 2500-2508.
34. McKiernan, K. A., Kaufman, J. N., Kucera-Thompson, J., & Binder, J. R. (2003). A parametric manipulation of factors affecting taskinduced deactivation in functional neuroimaging. Journal of Cognitive Neuroscience, 15(3), 394-408.
35. Minisini, A. M., Menis, J., Valent, F., Andreetta, C., Alessi, B., Pascoletti, G., Piga, A., Fasola, G., & Puglisi, F. (2009). Determinants of recovery from amenorrhea in premenopausal breast cancer patients receiving adjuvant chemotherapy in the taxane era. Anti-Cancer Drugs, 20(6), 503-507.
36. Nagel, I. E., Preuschhof, C., Li, S. C., Nyberg, L., Backman, L., Lindenberger, U., & Heekeren, H. R. (2011). Load modulation of BOLD response and connectivity predicts working memory performance in younger and older adults. Journal of Cognitive Neuroscience, 23(8), 2030-2045.
37. O'Brien, J. L., O'Keefe, K. M., Laviolette, P. S., Deluca, A. N., Blacker, D., Dickerson, B. C., & Sperling, R. A. (2010). Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline. Neurology, 74(24), 1969-1976.
38. Peper, J. S., van den Heuvel, M. P., Mandl, R. C. W., Pol, H. E. H., & van Honk, J. (2011). Sex steroids and connectivity in the human brain: a review of neuroimaging studies. Psychoneuroendocrinology, 36(8), 1101-1113.
39. Petrek, J. A., Naughton, M. J., Case, L. D., Paskett, E. D., Naftalis, E. Z., Singletary, S. E., & Sukumvanich, P. (2006). Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study. Journal of Clinical Oncology, 24(7), 1045-1051.
40. Pullens, M. J., De Vries, J., & Roukema, J. A. (2010). Subjective cognitive dysfunction in breast cancer patients: a systematic review. Psycho-Oncology, 19(11), 1127-1138.
41. Radloff, L. S. (1977). The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385-401.
42. Schagen, S. B., Muller, M. J., Boogerd, W., Mellenbergh, G. J., van Dam, F. S., Schagen, S. B., Muller, M. J., Boogerd, W., Mellenbergh, G. J., & van Dam, F. S. A. M. (2006). Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients. Journal of the National Cancer Institute, 98(23), 1742-1745.
43. Spielberger, C. D. (1983). State-trait anxiety inventory. Palo Alto: Consulting Psychologists Press, Inc.
44. Stearns, V., Schneider, B., Henry, N. L., Hayes, D. F., & Flockhart, D. A. (2006). Breast cancer treatment and ovarian failure: risk factors and emerging genetic determinants. Nature Reviews Cancer, 6(11), 886-893.
45. Sukumvanich, P., Case, L. D., Van Zee, K., Singletary, S. E., Paskett, E. D., Petrek, J. A., Naftalis, E., & Naughton, M. J. (2010). Incidence and time course of bleeding after long-term amenorrhea after breast cancer treatment: a prospective study. Cancer, 116(13), 3102-3111.
46. Swain, S. M., Land, S. R., Ritter, M. W., Costantino, J. P., Cecchini, R. S., Mamounas, E. P., Wolmark, N., & Ganz, P. A. (2009). Amenorrhea in premenopausal women on the doxorubicin-andcyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial. Breast Cancer Research and Treatment, 113(2), 315-320.
47. Swain, S. M., Jeong, J. H., Geyer, C. E., Jr., Costantino, J. P., Pajon, E. R., Fehrenbacher, L., Atkins, J. N., Polikoff, J., Vogel, V. G., Erban, J. K., Rastogi, P., Livingston, R. B., Perez, E. A., Mamounas, E. P., Land, S. R., Ganz, P. A., & Wolmark, N. (2010). Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer. The New England Journal of Medicine, 362(22), 2053-2065.
48. The Psychological Corporation. (1997). WAIS-III/WMS-III updated technical manual. San Antonio, TX: The Psychological Corporation.
49. The Psychological Corporation. (1999). Wechsler abbreviated scale of intelligence. San Antonio: The Psychological Corporation.
50. Turgeon, J. L., Carr, M. C., Maki, P. M., Mendelsohn, M. E., & Wise, P. M. (2006). Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: insights from basic science and clinical studies. Endocrine Reviews, 27(6), 575-605.
51. Vearncombe, K. J., & Pachana, N. A. (2009). Is cognitive functioning detrimentally affected after early, induced menopause? Menopause, 16(1), 188-198.
52. Vearncombe, K. J., Rolfe, M., Andrew, B., Pachana, N. A., Wright, M., & Beadle, G. (2011). Cognitive effects of chemotherapy-induced menopause in breast cancer. Clinical Neuropsychology, 25(8), 1295-1313.
53. Walshe, J. M., Denduluri, N., & Swain, S. M. (2006). Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer. Journal of Clinical Oncology, 24(36), 5769-5779.
54. Warne, G. L., Fairley, K. F., Hobbs, J. B., & Martin, F. I. (1973). Cyclophosphamide-induced ovarian failure. The New England Journal of Medicine, 289(22), 1159-1162.
55. Wilkinson, G. S. (1993). The Wide Range Achievement Test (WRAT3): Administration manual. Wilmington: Wide Range, Inc.
56. Zhao, L., O'Neill, K., & Diaz Brinton, R. (2005). Selective estrogen receptor modulators (SERMs) for the brain: current status and remaining challenges for developing NeuroSERMs. Brain Research. Brain Research Reviews, 49(3), 472-493.